Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07456423) titled 'Adenosine vs. Diltiazem' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Single (Investigator).

Primary Sponsor: Haseki Training and Research Hospital

Condition: Supraventricular Tachycardia (SVT) Atrioventricular Nodal Re Entrant Tachycardia

Intervention: Drug: Adenosine intravenous

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: July 1, 2024

Target Sample Size: 140

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07...